Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.

Abstract:

:Microsatellite instability, a well-established driver pathway in colorectal carcinogenesis, can develop in both sporadic and hereditary conditions via different molecular alterations in the DNA mismatch repair (MMR) genes. MMR protein immunohistochemistry (IHC) is currently widely used for the detection of MMR deficiency in solid tumors. The IHC test, however, can show varied staining patterns, posing challenges in the interpretation of the staining results in some cases. Here we report a case of an 80-year-old female with a colonic adenocarcinoma that exhibited an unusual "null" IHC staining pattern with complete loss of all four MMR proteins (MLH1, MSH2, MSH6, and PMS2). This led to subsequent MLH1 methylation testing and next generation sequencing which demonstrated that the loss of all MMR proteins was associated with concurrent promoter hypermethylation of MLH1 and double somatic truncating mutations in MSH2. These molecular findings, in conjunction with the patient's age being 80 years and the fact that the patient had no personal or family cancer history, indicated that the MMR deficiency was highly likely sporadic in nature. Thus, the stringent Lynch syndrome type surveillance programs were not recommended to the patient and her family members. This case illustrates a rare but important scenario where a null IHC phenotype signifies complex underlying molecular alternations that bear clinical management implications, highlighting the need for recognition and awareness of such unusual IHC staining patterns.

journal_name

Fam Cancer

journal_title

Familial cancer

authors

Wang T,Stadler ZK,Zhang L,Weiser MR,Basturk O,Hechtman JF,Vakiani E,Saltz LB,Klimstra DS,Shia J

doi

10.1007/s10689-017-0031-9

subject

Has Abstract

pub_date

2018-04-01 00:00:00

pages

225-228

issue

2

eissn

1389-9600

issn

1573-7292

pii

10.1007/s10689-017-0031-9

journal_volume

17

pub_type

杂志文章
  • Prediction models in Lynch syndrome.

    abstract::Prediction models for the identification of Lynch syndrome have been developed to quantify an individual's risk of carrying a mismatch repair gene mutation and help clinicians decide for whom further risk assessment and genetic testing is necessary. There are diverse clinical settings in which a healthcare provider ha...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-013-9632-0

    authors: Kastrinos F,Balmaña J,Syngal S

    更新日期:2013-06-01 00:00:00

  • Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.

    abstract::Genetic testing for cancer susceptibility genes is increasingly being integrated into medical care. Test results help inform risks of the individual being tested as well as family members who could benefit from knowing the results. The responsibility for informing relatives of genetic test results falls on the proband...

    journal_title:Familial cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s10689-016-9889-1

    authors: Daly MB,Montgomery S,Bingler R,Ruth K

    更新日期:2016-10-01 00:00:00

  • Hepatoblastoma in two siblings and familial adenomatous polyposis: causal nexus or coincidence?

    abstract::Infantile and childhood hepatoblastoma (HB) occurs more frequently in children with hereditary predisposition to familial adenomatous polyposis (FAP) than in the general population. The occurrence of HB in two infant siblings is reported. The sister died of the disease. The brother survived the HB and was later diagno...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9538-2

    authors: Evers C,Gaspar H,Kloor M,Bozukova G,Kadmon M,Keller M,Sutter C,Moog U

    更新日期:2012-09-01 00:00:00

  • Lack of germ-line mutations at the specific BRCA1-IRIS coding sequence in 114 Spanish high-risk breast/ovarian families.

    abstract::A new BRCA1 locus product called BRCA1-IRIS has been identified recently. High-risk breast/ovarian families have not been screened for germ-line mutations at the specific BRCA1-IRIS coding sequence, as it was considered merely as part of BRCA1 intron 11. Here we report the first comprehensive screening of germ-line mu...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-005-1236-x

    authors: de la Hoya M,Fernández JM,Sánchez de Abajo A,Tosar A,Díaz-Rubio E,Caldés T

    更新日期:2005-01-01 00:00:00

  • The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds.

    abstract::Li-Fraumeni syndrome (LFS) is a dominantly inherited cancer predisposition syndrome characterized by a wide spectrum of neoplasms occurring at young age. Germline mutations in the TP53 tumor suppressor gene have been identified in approximately 71 of LFS patients and 22 of Li-Fraumeni-like (LFL) patients. Mutations wi...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-004-1946-5

    authors: Siddiqui R,Onel K,Facio F,Nafa K,Diaz LR,Kauff N,Huang H,Robson M,Ellis N,Offit K

    更新日期:2005-01-01 00:00:00

  • Waiting and "weighted down": the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome.

    abstract::Li-Fraumeni Syndrome (LFS) is characterized by risk of multiple primary malignancies in diverse sites, pediatric onset, near complete penetrance by age 70 years, limited options for prevention, and substantial uncertainty regarding disease manifestation and prognosis. Forty-five families, including 117 individuals age...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-020-00173-6

    authors: Werner-Lin A,Young JL,Wilsnack C,Merrill SL,Groner V,Greene MH,Khincha PP

    更新日期:2020-07-01 00:00:00

  • Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations.

    abstract::The myeloproliferative neoplasms (MPN) are clonal, hematological malignancies that include polycythemia vera, essential thrombocythemia and primary myelofibrosis. While most cases of MPN are sporadic in nature, a familial pattern of inheritance is well recognised. The phenotype and status of the commonly acquired JAK2...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-014-9743-2

    authors: Langabeer SE,Haslam K,Linders J,Percy MJ,Conneally E,Hayat A,Hennessy B,Leahy M,Murphy K,Murray M,Ni Ainle F,Thornton P,Sargent J

    更新日期:2014-12-01 00:00:00

  • Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer.

    abstract::Germline mutations in the BRCA1 tumor suppressor gene predispose affected individuals to breast cancer; however, incomplete cancer penetrance and the presence of phenocopies in BRCA1 families also indicate genetic and environmental modifiers of breast cancer risk. In this study, we have tested the single nucleotide po...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-013-9647-6

    authors: Bielinska B,Gaj P,Kluska A,Nowakowska D,Balabas A,Dabrowska M,Niwinska A,Gruchota J,Zub R,Skasko E,Steffen J,Ostrowski J,Siedlecki JA

    更新日期:2013-12-01 00:00:00

  • Uroepithelial and kidney carcinoma in Lynch syndrome.

    abstract::Increased risk for urological tumors has been observed in mutation carriers with Lynch syndrome (LS). In this study, we evaluated the clinical features of uroepithelial (bladder and ureter) and kidney cancers in 974 Finnish mutation carriers. Altogether 30 patients had a total of 34 urological tumors: 12 ureter, 12 bl...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9526-6

    authors: Aarnio M,Säily M,Juhola M,Gylling A,Peltomäki P,Järvinen HJ,Mecklin JP

    更新日期:2012-09-01 00:00:00

  • The InSiGHT database: utilizing 100 years of insights into Lynch syndrome.

    abstract::This article provides a historical overview of the online database ( www.insight-group.org/mutations ) maintained by the International Society for Gastrointestinal Hereditary Tumours. The focus is on the mismatch repair genes which are mutated in Lynch Syndrome. APC, MUTYH and other genes are also an important part of...

    journal_title:Familial cancer

    pub_type: 历史文章,杂志文章

    doi:10.1007/s10689-013-9616-0

    authors: Plazzer JP,Sijmons RH,Woods MO,Peltomäki P,Thompson B,Den Dunnen JT,Macrae F

    更新日期:2013-06-01 00:00:00

  • Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.

    abstract::The risks of cancers other than breast and ovarian amongst BRCA1 and BRCA2 mutation carriers are based on relatively few family based studies with the risk of specific cancers tested in population based samples of cancers from founder populations. We assessed risks of "other cancers" in 268 BRCA1 families and 222 BRCA...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-011-9506-2

    authors: Moran A,O'Hara C,Khan S,Shack L,Woodward E,Maher ER,Lalloo F,Evans DG

    更新日期:2012-06-01 00:00:00

  • Hereditary ovarian cancer in Ashkenazi Jews.

    abstract::Ovarian cancer is the fourth leading cause of cancer deaths among American women. While women in both the Ashkenazi and non-Ashkenazi populations have an estimated 1.7% lifetime risk of acquiring malignancy, the proportion of hereditary ovarian cancer is much higher in the Ashkenazim. Most of this increased proportion...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-004-9552-0

    authors: Robles-Díaz L,Goldfrank DJ,Kauff ND,Robson M,Offit K

    更新日期:2004-01-01 00:00:00

  • Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.

    abstract::BRCA1 mutations predispose to early-onset breast cancer. We previously reported an association between absence of the common IGF1 19 CA-repeat allele (IGF1-19/-19) and being a BRCA1 mutation carrier in young women from breast cancer high-risk families. Others have reported a four-fold risk of premenopausal breast canc...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9141-0

    authors: Henningson M,Bågeman E,Sandberg T,Borg A,Olsson H,Jernström H

    更新日期:2007-01-01 00:00:00

  • Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.

    abstract::Founder mutations with a large impact in distinct populations have been described in Lynch syndrome. In Denmark, the MLH1 c.1667+2_1667_+8TAAATCAdelinsATTT mutation accounts for 25 % of the MLH1 mutant families. We used the national Danish hereditary nonpolyposis colorectal cancer register to estimate the cumulative l...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9552-4

    authors: Therkildsen C,Isinger-Ekstrand A,Ladelund S,Nissen A,Rambech E,Bernstein I,Nilbert M

    更新日期:2012-12-01 00:00:00

  • Determining the familial risk distribution of colorectal cancer: a data mining approach.

    abstract::This study was aimed to characterize the distribution of colorectal cancer risk using family history of cancers by data mining. Family histories for 10,066 colorectal cancer cases recruited to population cancer registries of the Colon Cancer Family Registry were analyzed using a data mining framework. A novel index wa...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-015-9860-6

    authors: Chau R,Jenkins MA,Buchanan DD,Ait Ouakrim D,Giles GG,Casey G,Gallinger S,Haile RW,Le Marchand L,Newcomb PA,Lindor NM,Hopper JL,Win AK

    更新日期:2016-04-01 00:00:00

  • Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.

    abstract::Comprehensive genomic cancer risk assessment (GCRA) helps patients, family members, and providers make informed choices about cancer screening, surgical and chemotherapeutic risk reduction, and genetically targeted cancer therapies. The increasing availability of multigene panel tests for clinical applications allows ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-018-0070-x

    authors: West AH,Blazer KR,Stoll J,Jones M,Weipert CM,Nielsen SM,Kupfer SS,Weitzel JN,Olopade OI

    更新日期:2018-10-01 00:00:00

  • Does and should breast cancer genetic counselling include lifestyle advice?

    abstract::To optimally inform counselees about their and their relatives' risks, information about lifestyle risk factors, e.g. physical activity and alcohol consumption, might be discussed in breast cancer genetic counselling. This study explored whether lifestyle was discussed, on whose initiative, whether information and/or ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-013-9672-5

    authors: Albada A,Vernooij M,van Osch L,Pijpe A,van Dulmen S,Ausems MG

    更新日期:2014-03-01 00:00:00

  • Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.

    abstract::Li-Fraumeni syndrome (LFS) is an autosomal dominantly inherited cancer predisposition syndrome characterized by a combination of tumors including sarcoma, breast cancer, brain tumors, adrenocortical carcinoma and leukemia. Germline mutations in the tumor suppressor gene TP53 are associated with LFS. We present a famil...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-006-9115-7

    authors: van Hest LP,Ruijs MW,Wagner A,van der Meer CA,Verhoef S,van't Veer LJ,Meijers-Heijboer H

    更新日期:2007-01-01 00:00:00

  • Standards of care in diagnosis and testing for hereditary colon cancer.

    abstract::Inherited colorectal cancer predisposition involves a rather heterogeneous range of rare, yet relatively well-defined disorders, including Familial Adenomatous Polyposis (FAP), Hereditary Non-polyposis Colorectal Cancer (HNPCC) or Lynch syndrome, Peutz-Jeghers syndrome, Juvenile Polyposis, and their respective variant...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9159-3

    authors: Lynch PM

    更新日期:2008-01-01 00:00:00

  • Unmet support needs and distress among women with a BRCA1/2 mutation.

    abstract::Distress levels among female BRCA1/2 mutation carriers can be similar to levels found among breast cancer patients. While psychological distress has been associated with unmet needs among cancer patients no study has examined this among BRCA1/2 mutation carriers. The objectives of this study were to: (1) describe the ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9596-5

    authors: Farrelly A,White V,Meiser B,Jefford M,Young MA,Ieropoli S,Winship I,Duffy J

    更新日期:2013-09-01 00:00:00

  • Microsatellite instability testing in Korean patients with colorectal cancer.

    abstract::Microsatellite instability (MSI) testing is useful for identifying patients with hereditary nonpolyposis colorectal cancer and detecting sporadic colorectal cancer that develops through replication error pathways. A pentaplex panel is recommended by the National Cancer Institute for MSI testing, but simplified mononuc...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9536-4

    authors: Oh JR,Kim DW,Lee HS,Lee HE,Lee SM,Jang JH,Kang SB,Ku JL,Jeong SY,Park JG

    更新日期:2012-09-01 00:00:00

  • Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.

    abstract::Since restorative proctocolectomy (RPC) with ileal-pouch anal anastomosis (IPAA) removes the entire diseased mucosa, it has become firmly established as the standard operative procedure of choice for familial adenomatous polyposis (FAP). Many technical controversies still persist, such as mesenteric lengthening techni...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-005-5672-4

    authors: Kartheuser A,Stangherlin P,Brandt D,Remue C,Sempoux C

    更新日期:2006-01-01 00:00:00

  • Chemoprevention with special reference to inherited colorectal cancer.

    abstract::Familial Adenomatous Polyposis (FAP) is a model for the adenoma-carcinoma sequence in several respects. One important area in which FAP serves as a model is chemoprevention. Early prevention trials mainly utilized micronutrients and were largely unsuccessful in preventing or causing regression of adenomas. A new era w...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9158-4

    authors: Lynch PM

    更新日期:2008-01-01 00:00:00

  • Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.

    abstract::To characterize the frequency of germline mutations associated with Lynch syndrome and review the potential expanded differential diagnoses in very early onset colorectal cancer (CRC) cases without apparent polyposis. Retrospectively reviewed medical records of 96 probands with CRC diagnosed prior to age 36 from three...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9290-4

    authors: Jasperson KW,Vu TM,Schwab AL,Neklason DW,Rodriguez-Bigas MA,Burt RW,Weitzel JN

    更新日期:2010-06-01 00:00:00

  • Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.

    abstract::Through germline multigene panel testing, we discovered the co-occurrence of Lynch syndrome due to a PMS2 mutation and juvenile polyposis syndrome due to a BMPR1A mutation in a young man with synchronous bladder and colorectal cancers and a family history of colorectal polyps. To our knowledge, this is the first repor...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-017-0012-z

    authors: Silva-Smith R,Sussman DA

    更新日期:2018-01-01 00:00:00

  • Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations.

    abstract::Germ-line mutations in the tumour suppressor genes BRCA1 and BRCA2 predispose to breast and ovarian cancer. Since 1999 we have performed mutational screening of breast and/or ovarian cancer patients in East Denmark. During this period we have identified 40 novel sequence variations in BRCA1 and BRCA2 in high risk brea...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-011-9422-5

    authors: Hansen TV,Jønson L,Steffensen AY,Andersen MK,Kjaergaard S,Gerdes AM,Ejlertsen B,Nielsen FC

    更新日期:2011-06-01 00:00:00

  • Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency.

    abstract::Constitutional mismatch repair deficiency syndrome (CMMRD) is a rare autosomal recessive predisposition to colorectal polyposis and other malignancies, often childhood-onset, that is caused by biallelic inheritance of mutations in the same mismatch repair gene. Here, we describe a patient with a clinical diagnosis of ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9902-8

    authors: Mork ME,Borras E,Taggart MW,Cuddy A,Bannon SA,You YN,Lynch PM,Ramirez PT,Rodriguez-Bigas MA,Vilar E

    更新日期:2016-10-01 00:00:00

  • Are prediction models for Lynch syndrome valid for probands with endometrial cancer?

    abstract::Currently, three prediction models are used to predict a patient's risk of having Lynch syndrome (LS). These models have been validated in probands with colorectal cancer (CRC), but not in probands presenting with endometrial cancer (EMC). Thus, the aim was to determine the performance of these prediction models in wo...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9273-5

    authors: Backes FJ,Hampel H,Backes KA,Vaccarello L,Lewandowski G,Bell JA,Reid GC,Copeland LJ,Fowler JM,Cohn DE

    更新日期:2009-01-01 00:00:00

  • A survey of APC mutations in Quebec.

    abstract::This is an 11-year survey of molecular analysis of APC germline mutations for the province of Quebec done at the Molecular Pathology Unit of the Jewish General Hospital which offers genetic testing for hereditary forms of colorectal cancer for the whole of Quebec province. We report on 47 unique mutations seen in 66 f...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-011-9468-4

    authors: Jarry J,Brunet JS,Laframboise R,Drouin R,Latreille J,Richard C,Gekas J,Maranda B,Monczak Y,Wong N,Pouchet C,Zaor S,Kasprzak L,Palma L,Wu MK,Tischkowitz M,Foulkes WD,Chong G

    更新日期:2011-12-01 00:00:00

  • Hereditary medullary thyroid carcinoma: the management dilemma.

    abstract::Hereditary medullary thyroid carcinoma (hereditary MTC) is a rare malignancy, accounting for 25-30% of all MTC. It occurs as part of multiple endocrine neoplasia type 2 (MEN 2). Autosomal dominant gain-of-function mutations in the RET proto-oncogene is the cause of the disease, in which the common mutations are codons...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-011-9501-7

    authors: Zhou P,Liu J,Cheng SW,Wang B,Yang R,Peng L

    更新日期:2012-06-01 00:00:00